+关注
鑫潼杍
暂无个人介绍
IP属地：海外
93
关注
0
粉丝
2
主题
0
勋章
主贴
热门
鑫潼杍
2020-11-11
哪里看到小鹏涨0.6%？
新能源汽车股分化，理想汽车跌6%，小鹏汽车上涨
鑫潼杍
2020-09-28
$世纪华通(002602)$
这股真垃圾呀
鑫潼杍
2020-07-17
业绩说得这么好，股票尿成这样，好意思吗？
海普瑞(09989)二季度各业务全面发力 上半年扣非净利润预计同比大幅上涨620%-690%
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3546151717554729,"uuid":"3546151717554729","gmtCreate":1583059213575,"gmtModify":1605060508724,"name":"鑫潼杍","pinyin":"xt杍xintong杍","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/e7294c10d1782e8005572ae9dd2f4a20","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":93,"tweetSize":3,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":2,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":37,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.04.10","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.15%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.06%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"海外","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":305477563,"gmtCreate":1605050392552,"gmtModify":1703835959003,"author":{"id":"3546151717554729","authorId":"3546151717554729","name":"鑫潼杍","avatar":"https://static.tigerbbs.com/e7294c10d1782e8005572ae9dd2f4a20","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"哪里看到小鹏涨0.6%？","listText":"哪里看到小鹏涨0.6%？","text":"哪里看到小鹏涨0.6%？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/305477563","repostId":"1169746944","repostType":4,"repost":{"id":"1169746944","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1605021556,"share":"https://www.laohu8.com/m/news/1169746944?lang=&edition=full","pubTime":"2020-11-10 23:19","market":"us","language":"zh","title":"新能源汽车股分化，理想汽车跌6%，小鹏汽车上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1169746944","media":"老虎资讯综合","summary":"周二，美股新能源车板块涨跌不一。截至发稿，理想汽车跌6.2%，蔚来跌5%，特斯拉跌2.5%。小鹏汽车走势较强，涨幅0.6%。今日消息，摩根大通分析师Nick Lai将小鹏汽车的目标价从27美元上调至4","content":"<p>周二，美股新能源车板块涨跌不一。截至发稿，<a href=\"https://laohu8.com/S/LI\">理想汽车</a>跌6.2%，<a href=\"https://laohu8.com/S/NIO\">蔚来</a>跌5%，<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>跌2.5%。</p><p><a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>走势较强，涨幅0.6%。今日消息，<a href=\"https://laohu8.com/S/JPM\">摩根大通</a>分析师Nick Lai将小鹏汽车的目标价从27美元上调至43美元，并重申对该股的“买入”评级。</p><p><img src=\"https://static.tigerbbs.com/1342269c7b147932c9ae2129841bca4f\" tg-width=\"840\" tg-height=\"470\"></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>新能源汽车股分化，理想汽车跌6%，小鹏汽车上涨</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n新能源汽车股分化，理想汽车跌6%，小鹏汽车上涨\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2020-11-10 23:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>周二，美股新能源车板块涨跌不一。截至发稿，<a href=\"https://laohu8.com/S/LI\">理想汽车</a>跌6.2%，<a href=\"https://laohu8.com/S/NIO\">蔚来</a>跌5%，<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>跌2.5%。</p><p><a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>走势较强，涨幅0.6%。今日消息，<a href=\"https://laohu8.com/S/JPM\">摩根大通</a>分析师Nick Lai将小鹏汽车的目标价从27美元上调至43美元，并重申对该股的“买入”评级。</p><p><img src=\"https://static.tigerbbs.com/1342269c7b147932c9ae2129841bca4f\" tg-width=\"840\" tg-height=\"470\"></p><p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/ec81a92314abfafc084fe3a61f3e9862","relate_stocks":{"XPEV":"小鹏汽车","TSLA":"特斯拉","LI":"理想汽车","NIO":"蔚来"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169746944","content_text":"周二，美股新能源车板块涨跌不一。截至发稿，理想汽车跌6.2%，蔚来跌5%，特斯拉跌2.5%。小鹏汽车走势较强，涨幅0.6%。今日消息，摩根大通分析师Nick Lai将小鹏汽车的目标价从27美元上调至43美元，并重申对该股的“买入”评级。","news_type":1},"isVote":1,"tweetType":1,"viewCount":329,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":974570494,"gmtCreate":1601265148218,"gmtModify":1703823757712,"author":{"id":"3546151717554729","authorId":"3546151717554729","name":"鑫潼杍","avatar":"https://static.tigerbbs.com/e7294c10d1782e8005572ae9dd2f4a20","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/002602\">$世纪华通(002602)$</a>这股真垃圾呀","listText":"<a href=\"https://laohu8.com/S/002602\">$世纪华通(002602)$</a>这股真垃圾呀","text":"$世纪华通(002602)$这股真垃圾呀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/974570494","isVote":1,"tweetType":1,"viewCount":294,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":941561312,"gmtCreate":1594966293136,"gmtModify":1704207580076,"author":{"id":"3546151717554729","authorId":"3546151717554729","name":"鑫潼杍","avatar":"https://static.tigerbbs.com/e7294c10d1782e8005572ae9dd2f4a20","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"业绩说得这么好，股票尿成这样，好意思吗？","listText":"业绩说得这么好，股票尿成这样，好意思吗？","text":"业绩说得这么好，股票尿成这样，好意思吗？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/941561312","repostId":"2051403910","repostType":2,"repost":{"id":"2051403910","pubTimestamp":1594774800,"share":"https://www.laohu8.com/m/news/2051403910?lang=&edition=full","pubTime":"2020-07-15 09:00","market":"hk","language":"zh","title":"海普瑞(09989)二季度各业务全面发力 上半年扣非净利润预计同比大幅上涨620%-690%","url":"https://stock-news.laohu8.com/highlight/detail?id=2051403910","media":"智通财经网","summary":"2020年上半年，海普瑞归属于上市公司股东的净利润预计达5.46-6.01亿元。","content":"<html><body><article>\n<p>智通财经APP获悉，7月14日，深圳市<a href=\"https://laohu8.com/S/002399\">海普瑞</a>药业集团股份有限公司(09989)(以下简称“<a href=\"https://laohu8.com/S/09989\">海普瑞</a>”)发布了2020年半年度业绩预告。作为上市后的首份成绩单， \n2020年上半年，海普瑞归属于上市公司股东的净利润预计达5.46-6.01亿元。其中，预计第二季度单季度归母净利润为29,110.93-34,574.95万元，相较于上年同期的3,936.86万元预计同比增长639%至778%。</p><p>值得关注的是，公告显示，海普瑞2020年上半年扣非净利润预计实现大幅增长，扣非归母净利润预计同比增长620%-690%，主要原因包括：制剂业务成为肝素产业链利润增长的主要驱动力;在去年下半年公司与客户定价模式的调整下，原材料业务实现成本波动的有效传导，毛利率实现大幅上升; \nCDMO业务收入增长、毛利额及毛利率增长边际效应显著。</p><p>作为全球肝素龙头，海普瑞现已对肝素全产业链实现垂直整合一体化，主力产品在全球市场的拓展力度也在不断加大。据智通财经APP了解到，截至目前，其制剂产品已经进入了欧盟前7大依诺肝素市场的数十个欧洲国家。</p><p>其中，Inhixa品牌依诺肝素注射液近期再度获得批准在瑞士上市，则进一步加速了海普瑞在欧洲市场的全面覆盖。在产能方面，海普瑞坪山产业园正式获得EMA批准成为Inhixa所需依诺肝素钠原料药生产场地，为其满足在欧洲市场加速扩张的原材料需求提供保障，并进一步加强其依诺肝素制剂的全球产能。</p><p>除此之外，海普瑞还通过自主申报和与已上市品种合作的方式进入美国市场。于国内市场，其依诺肝素制剂注射剂一致性评价中排名第2-6位，目前已完成技术审评，后续则有望率先通过一致性评价，并在集采中受益。作为公司的主力品种，依诺肝素制剂在全球市场的加速扩张，则将成为公司业务增长的重要引擎。</p><p>据智通财经APP了解，在心脑血管及肿瘤两大高致死率疾病上，海普瑞多个核心创新药管线品种于今年以来也获得了突破性进展。其中，海普瑞参投参股公司Resverlogix \nCorp.研发的RVX-208于今年2月获得FDA突破性疗法认定(BTD)，该药物主要治疗II型糖尿病患者所发生的重大心脑血管不良事件症状。据资料显示，过去5年中，FDA在心脑血管领域共仅授予过二项BTD，而RVX-208就获得其中一项。</p><p>6月下旬，该品种的关键性III期临床方案再度获得FDA批准，且FDA同意，一旦其中期数据分析结果显示有效性与安全性达标，该药物即可提交NDA申请获得FDA批准上市。根据GBI \nResearch预测，到2021年，II型糖尿病全球市场将从2014年的235亿美元增长到390亿美元，RVX-208一旦获批上市，将迎来千亿蓝海市场。</p><p>此外，海普瑞参股子公司OncoQuest Inc.也于今年4月拟交易资产并借壳韩国公司Dual \nIndustrial实现境外上市。据了解，若本次交易成功，OncoQuest将得以使用Dual先期融得的7500万美元，有望进一步满足其研发的原发卵巢癌一线抗体免疫治疗药物Oregovomab全球多中心III期临床试验的研发创新所需，加速其临床研发进程。</p><p>其中，根据Global \nData发布的最新研究预测显示，全球卵巢癌市场空间在2028年预计将达到67亿美元，市场空间巨大。而海普瑞拥有Oregovomab大中华区域独家产品开发及商业化权益，则有望持续受益。</p><p>目前，海普瑞已成功登陆H股市场，实现“A+H”双平台资本市场的加持。随着其主力品种在全球份额的持续扩张、CDMO业务的快速增长以及创新药管线品种商业化进程的进一步提速，公司全年业绩增长的趋势将更加清晰，未来发展将更加值得期待。</p> </article></body></html>","source":"highlight_zhitongcaijin","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>海普瑞(09989)二季度各业务全面发力 上半年扣非净利润预计同比大幅上涨620%-690%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n海普瑞(09989)二季度各业务全面发力 上半年扣非净利润预计同比大幅上涨620%-690%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-07-15 09:00 北京时间 <a href=http://www.zhitongcaijing.com/content/detail/318263.html><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，7月14日，深圳市海普瑞药业集团股份有限公司(09989)(以下简称“海普瑞”)发布了2020年半年度业绩预告。作为上市后的首份成绩单， \n2020年上半年，海普瑞归属于上市公司股东的净利润预计达5.46-6.01亿元。其中，预计第二季度单季度归母净利润为29,110.93-34,574.95万元，相较于上年同期的3,936.86万元预计同比增长639%至778%。值得关注的是...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/318263.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://img.zhitongcaijing.com/image/20200715/20200715083047_11432.png?x-oss-process=image/format,jpg/quality,Q_80","relate_stocks":{"09989":"海普瑞","002399":"海普瑞"},"source_url":"http://www.zhitongcaijing.com/content/detail/318263.html","is_english":false,"share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","article_id":"2051403910","content_text":"智通财经APP获悉，7月14日，深圳市海普瑞药业集团股份有限公司(09989)(以下简称“海普瑞”)发布了2020年半年度业绩预告。作为上市后的首份成绩单， \n2020年上半年，海普瑞归属于上市公司股东的净利润预计达5.46-6.01亿元。其中，预计第二季度单季度归母净利润为29,110.93-34,574.95万元，相较于上年同期的3,936.86万元预计同比增长639%至778%。值得关注的是，公告显示，海普瑞2020年上半年扣非净利润预计实现大幅增长，扣非归母净利润预计同比增长620%-690%，主要原因包括：制剂业务成为肝素产业链利润增长的主要驱动力;在去年下半年公司与客户定价模式的调整下，原材料业务实现成本波动的有效传导，毛利率实现大幅上升; \nCDMO业务收入增长、毛利额及毛利率增长边际效应显著。作为全球肝素龙头，海普瑞现已对肝素全产业链实现垂直整合一体化，主力产品在全球市场的拓展力度也在不断加大。据智通财经APP了解到，截至目前，其制剂产品已经进入了欧盟前7大依诺肝素市场的数十个欧洲国家。其中，Inhixa品牌依诺肝素注射液近期再度获得批准在瑞士上市，则进一步加速了海普瑞在欧洲市场的全面覆盖。在产能方面，海普瑞坪山产业园正式获得EMA批准成为Inhixa所需依诺肝素钠原料药生产场地，为其满足在欧洲市场加速扩张的原材料需求提供保障，并进一步加强其依诺肝素制剂的全球产能。除此之外，海普瑞还通过自主申报和与已上市品种合作的方式进入美国市场。于国内市场，其依诺肝素制剂注射剂一致性评价中排名第2-6位，目前已完成技术审评，后续则有望率先通过一致性评价，并在集采中受益。作为公司的主力品种，依诺肝素制剂在全球市场的加速扩张，则将成为公司业务增长的重要引擎。据智通财经APP了解，在心脑血管及肿瘤两大高致死率疾病上，海普瑞多个核心创新药管线品种于今年以来也获得了突破性进展。其中，海普瑞参投参股公司Resverlogix \nCorp.研发的RVX-208于今年2月获得FDA突破性疗法认定(BTD)，该药物主要治疗II型糖尿病患者所发生的重大心脑血管不良事件症状。据资料显示，过去5年中，FDA在心脑血管领域共仅授予过二项BTD，而RVX-208就获得其中一项。6月下旬，该品种的关键性III期临床方案再度获得FDA批准，且FDA同意，一旦其中期数据分析结果显示有效性与安全性达标，该药物即可提交NDA申请获得FDA批准上市。根据GBI \nResearch预测，到2021年，II型糖尿病全球市场将从2014年的235亿美元增长到390亿美元，RVX-208一旦获批上市，将迎来千亿蓝海市场。此外，海普瑞参股子公司OncoQuest Inc.也于今年4月拟交易资产并借壳韩国公司Dual \nIndustrial实现境外上市。据了解，若本次交易成功，OncoQuest将得以使用Dual先期融得的7500万美元，有望进一步满足其研发的原发卵巢癌一线抗体免疫治疗药物Oregovomab全球多中心III期临床试验的研发创新所需，加速其临床研发进程。其中，根据Global \nData发布的最新研究预测显示，全球卵巢癌市场空间在2028年预计将达到67亿美元，市场空间巨大。而海普瑞拥有Oregovomab大中华区域独家产品开发及商业化权益，则有望持续受益。目前，海普瑞已成功登陆H股市场，实现“A+H”双平台资本市场的加持。随着其主力品种在全球份额的持续扩张、CDMO业务的快速增长以及创新药管线品种商业化进程的进一步提速，公司全年业绩增长的趋势将更加清晰，未来发展将更加值得期待。","news_type":1},"isVote":1,"tweetType":1,"viewCount":353,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":974570494,"gmtCreate":1601265148218,"gmtModify":1703823757712,"author":{"id":"3546151717554729","authorId":"3546151717554729","name":"鑫潼杍","avatar":"https://static.tigerbbs.com/e7294c10d1782e8005572ae9dd2f4a20","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/002602\">$世纪华通(002602)$</a>这股真垃圾呀","listText":"<a href=\"https://laohu8.com/S/002602\">$世纪华通(002602)$</a>这股真垃圾呀","text":"$世纪华通(002602)$这股真垃圾呀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/974570494","isVote":1,"tweetType":1,"viewCount":294,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":305477563,"gmtCreate":1605050392552,"gmtModify":1703835959003,"author":{"id":"3546151717554729","authorId":"3546151717554729","name":"鑫潼杍","avatar":"https://static.tigerbbs.com/e7294c10d1782e8005572ae9dd2f4a20","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"哪里看到小鹏涨0.6%？","listText":"哪里看到小鹏涨0.6%？","text":"哪里看到小鹏涨0.6%？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/305477563","repostId":"1169746944","repostType":4,"repost":{"id":"1169746944","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1605021556,"share":"https://www.laohu8.com/m/news/1169746944?lang=&edition=full","pubTime":"2020-11-10 23:19","market":"us","language":"zh","title":"新能源汽车股分化，理想汽车跌6%，小鹏汽车上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1169746944","media":"老虎资讯综合","summary":"周二，美股新能源车板块涨跌不一。截至发稿，理想汽车跌6.2%，蔚来跌5%，特斯拉跌2.5%。小鹏汽车走势较强，涨幅0.6%。今日消息，摩根大通分析师Nick Lai将小鹏汽车的目标价从27美元上调至4","content":"<p>周二，美股新能源车板块涨跌不一。截至发稿，<a href=\"https://laohu8.com/S/LI\">理想汽车</a>跌6.2%，<a href=\"https://laohu8.com/S/NIO\">蔚来</a>跌5%，<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>跌2.5%。</p><p><a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>走势较强，涨幅0.6%。今日消息，<a href=\"https://laohu8.com/S/JPM\">摩根大通</a>分析师Nick Lai将小鹏汽车的目标价从27美元上调至43美元，并重申对该股的“买入”评级。</p><p><img src=\"https://static.tigerbbs.com/1342269c7b147932c9ae2129841bca4f\" tg-width=\"840\" tg-height=\"470\"></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>新能源汽车股分化，理想汽车跌6%，小鹏汽车上涨</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n新能源汽车股分化，理想汽车跌6%，小鹏汽车上涨\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2020-11-10 23:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>周二，美股新能源车板块涨跌不一。截至发稿，<a href=\"https://laohu8.com/S/LI\">理想汽车</a>跌6.2%，<a href=\"https://laohu8.com/S/NIO\">蔚来</a>跌5%，<a href=\"https://laohu8.com/S/TSLA\">特斯拉</a>跌2.5%。</p><p><a href=\"https://laohu8.com/S/XPEV\">小鹏汽车</a>走势较强，涨幅0.6%。今日消息，<a href=\"https://laohu8.com/S/JPM\">摩根大通</a>分析师Nick Lai将小鹏汽车的目标价从27美元上调至43美元，并重申对该股的“买入”评级。</p><p><img src=\"https://static.tigerbbs.com/1342269c7b147932c9ae2129841bca4f\" tg-width=\"840\" tg-height=\"470\"></p><p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/ec81a92314abfafc084fe3a61f3e9862","relate_stocks":{"XPEV":"小鹏汽车","TSLA":"特斯拉","LI":"理想汽车","NIO":"蔚来"},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169746944","content_text":"周二，美股新能源车板块涨跌不一。截至发稿，理想汽车跌6.2%，蔚来跌5%，特斯拉跌2.5%。小鹏汽车走势较强，涨幅0.6%。今日消息，摩根大通分析师Nick Lai将小鹏汽车的目标价从27美元上调至43美元，并重申对该股的“买入”评级。","news_type":1},"isVote":1,"tweetType":1,"viewCount":329,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":941561312,"gmtCreate":1594966293136,"gmtModify":1704207580076,"author":{"id":"3546151717554729","authorId":"3546151717554729","name":"鑫潼杍","avatar":"https://static.tigerbbs.com/e7294c10d1782e8005572ae9dd2f4a20","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"业绩说得这么好，股票尿成这样，好意思吗？","listText":"业绩说得这么好，股票尿成这样，好意思吗？","text":"业绩说得这么好，股票尿成这样，好意思吗？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/941561312","repostId":"2051403910","repostType":2,"repost":{"id":"2051403910","pubTimestamp":1594774800,"share":"https://www.laohu8.com/m/news/2051403910?lang=&edition=full","pubTime":"2020-07-15 09:00","market":"hk","language":"zh","title":"海普瑞(09989)二季度各业务全面发力 上半年扣非净利润预计同比大幅上涨620%-690%","url":"https://stock-news.laohu8.com/highlight/detail?id=2051403910","media":"智通财经网","summary":"2020年上半年，海普瑞归属于上市公司股东的净利润预计达5.46-6.01亿元。","content":"<html><body><article>\n<p>智通财经APP获悉，7月14日，深圳市<a href=\"https://laohu8.com/S/002399\">海普瑞</a>药业集团股份有限公司(09989)(以下简称“<a href=\"https://laohu8.com/S/09989\">海普瑞</a>”)发布了2020年半年度业绩预告。作为上市后的首份成绩单， \n2020年上半年，海普瑞归属于上市公司股东的净利润预计达5.46-6.01亿元。其中，预计第二季度单季度归母净利润为29,110.93-34,574.95万元，相较于上年同期的3,936.86万元预计同比增长639%至778%。</p><p>值得关注的是，公告显示，海普瑞2020年上半年扣非净利润预计实现大幅增长，扣非归母净利润预计同比增长620%-690%，主要原因包括：制剂业务成为肝素产业链利润增长的主要驱动力;在去年下半年公司与客户定价模式的调整下，原材料业务实现成本波动的有效传导，毛利率实现大幅上升; \nCDMO业务收入增长、毛利额及毛利率增长边际效应显著。</p><p>作为全球肝素龙头，海普瑞现已对肝素全产业链实现垂直整合一体化，主力产品在全球市场的拓展力度也在不断加大。据智通财经APP了解到，截至目前，其制剂产品已经进入了欧盟前7大依诺肝素市场的数十个欧洲国家。</p><p>其中，Inhixa品牌依诺肝素注射液近期再度获得批准在瑞士上市，则进一步加速了海普瑞在欧洲市场的全面覆盖。在产能方面，海普瑞坪山产业园正式获得EMA批准成为Inhixa所需依诺肝素钠原料药生产场地，为其满足在欧洲市场加速扩张的原材料需求提供保障，并进一步加强其依诺肝素制剂的全球产能。</p><p>除此之外，海普瑞还通过自主申报和与已上市品种合作的方式进入美国市场。于国内市场，其依诺肝素制剂注射剂一致性评价中排名第2-6位，目前已完成技术审评，后续则有望率先通过一致性评价，并在集采中受益。作为公司的主力品种，依诺肝素制剂在全球市场的加速扩张，则将成为公司业务增长的重要引擎。</p><p>据智通财经APP了解，在心脑血管及肿瘤两大高致死率疾病上，海普瑞多个核心创新药管线品种于今年以来也获得了突破性进展。其中，海普瑞参投参股公司Resverlogix \nCorp.研发的RVX-208于今年2月获得FDA突破性疗法认定(BTD)，该药物主要治疗II型糖尿病患者所发生的重大心脑血管不良事件症状。据资料显示，过去5年中，FDA在心脑血管领域共仅授予过二项BTD，而RVX-208就获得其中一项。</p><p>6月下旬，该品种的关键性III期临床方案再度获得FDA批准，且FDA同意，一旦其中期数据分析结果显示有效性与安全性达标，该药物即可提交NDA申请获得FDA批准上市。根据GBI \nResearch预测，到2021年，II型糖尿病全球市场将从2014年的235亿美元增长到390亿美元，RVX-208一旦获批上市，将迎来千亿蓝海市场。</p><p>此外，海普瑞参股子公司OncoQuest Inc.也于今年4月拟交易资产并借壳韩国公司Dual \nIndustrial实现境外上市。据了解，若本次交易成功，OncoQuest将得以使用Dual先期融得的7500万美元，有望进一步满足其研发的原发卵巢癌一线抗体免疫治疗药物Oregovomab全球多中心III期临床试验的研发创新所需，加速其临床研发进程。</p><p>其中，根据Global \nData发布的最新研究预测显示，全球卵巢癌市场空间在2028年预计将达到67亿美元，市场空间巨大。而海普瑞拥有Oregovomab大中华区域独家产品开发及商业化权益，则有望持续受益。</p><p>目前，海普瑞已成功登陆H股市场，实现“A+H”双平台资本市场的加持。随着其主力品种在全球份额的持续扩张、CDMO业务的快速增长以及创新药管线品种商业化进程的进一步提速，公司全年业绩增长的趋势将更加清晰，未来发展将更加值得期待。</p> </article></body></html>","source":"highlight_zhitongcaijin","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>海普瑞(09989)二季度各业务全面发力 上半年扣非净利润预计同比大幅上涨620%-690%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n海普瑞(09989)二季度各业务全面发力 上半年扣非净利润预计同比大幅上涨620%-690%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-07-15 09:00 北京时间 <a href=http://www.zhitongcaijing.com/content/detail/318263.html><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，7月14日，深圳市海普瑞药业集团股份有限公司(09989)(以下简称“海普瑞”)发布了2020年半年度业绩预告。作为上市后的首份成绩单， \n2020年上半年，海普瑞归属于上市公司股东的净利润预计达5.46-6.01亿元。其中，预计第二季度单季度归母净利润为29,110.93-34,574.95万元，相较于上年同期的3,936.86万元预计同比增长639%至778%。值得关注的是...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/318263.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://img.zhitongcaijing.com/image/20200715/20200715083047_11432.png?x-oss-process=image/format,jpg/quality,Q_80","relate_stocks":{"09989":"海普瑞","002399":"海普瑞"},"source_url":"http://www.zhitongcaijing.com/content/detail/318263.html","is_english":false,"share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","article_id":"2051403910","content_text":"智通财经APP获悉，7月14日，深圳市海普瑞药业集团股份有限公司(09989)(以下简称“海普瑞”)发布了2020年半年度业绩预告。作为上市后的首份成绩单， \n2020年上半年，海普瑞归属于上市公司股东的净利润预计达5.46-6.01亿元。其中，预计第二季度单季度归母净利润为29,110.93-34,574.95万元，相较于上年同期的3,936.86万元预计同比增长639%至778%。值得关注的是，公告显示，海普瑞2020年上半年扣非净利润预计实现大幅增长，扣非归母净利润预计同比增长620%-690%，主要原因包括：制剂业务成为肝素产业链利润增长的主要驱动力;在去年下半年公司与客户定价模式的调整下，原材料业务实现成本波动的有效传导，毛利率实现大幅上升; \nCDMO业务收入增长、毛利额及毛利率增长边际效应显著。作为全球肝素龙头，海普瑞现已对肝素全产业链实现垂直整合一体化，主力产品在全球市场的拓展力度也在不断加大。据智通财经APP了解到，截至目前，其制剂产品已经进入了欧盟前7大依诺肝素市场的数十个欧洲国家。其中，Inhixa品牌依诺肝素注射液近期再度获得批准在瑞士上市，则进一步加速了海普瑞在欧洲市场的全面覆盖。在产能方面，海普瑞坪山产业园正式获得EMA批准成为Inhixa所需依诺肝素钠原料药生产场地，为其满足在欧洲市场加速扩张的原材料需求提供保障，并进一步加强其依诺肝素制剂的全球产能。除此之外，海普瑞还通过自主申报和与已上市品种合作的方式进入美国市场。于国内市场，其依诺肝素制剂注射剂一致性评价中排名第2-6位，目前已完成技术审评，后续则有望率先通过一致性评价，并在集采中受益。作为公司的主力品种，依诺肝素制剂在全球市场的加速扩张，则将成为公司业务增长的重要引擎。据智通财经APP了解，在心脑血管及肿瘤两大高致死率疾病上，海普瑞多个核心创新药管线品种于今年以来也获得了突破性进展。其中，海普瑞参投参股公司Resverlogix \nCorp.研发的RVX-208于今年2月获得FDA突破性疗法认定(BTD)，该药物主要治疗II型糖尿病患者所发生的重大心脑血管不良事件症状。据资料显示，过去5年中，FDA在心脑血管领域共仅授予过二项BTD，而RVX-208就获得其中一项。6月下旬，该品种的关键性III期临床方案再度获得FDA批准，且FDA同意，一旦其中期数据分析结果显示有效性与安全性达标，该药物即可提交NDA申请获得FDA批准上市。根据GBI \nResearch预测，到2021年，II型糖尿病全球市场将从2014年的235亿美元增长到390亿美元，RVX-208一旦获批上市，将迎来千亿蓝海市场。此外，海普瑞参股子公司OncoQuest Inc.也于今年4月拟交易资产并借壳韩国公司Dual \nIndustrial实现境外上市。据了解，若本次交易成功，OncoQuest将得以使用Dual先期融得的7500万美元，有望进一步满足其研发的原发卵巢癌一线抗体免疫治疗药物Oregovomab全球多中心III期临床试验的研发创新所需，加速其临床研发进程。其中，根据Global \nData发布的最新研究预测显示，全球卵巢癌市场空间在2028年预计将达到67亿美元，市场空间巨大。而海普瑞拥有Oregovomab大中华区域独家产品开发及商业化权益，则有望持续受益。目前，海普瑞已成功登陆H股市场，实现“A+H”双平台资本市场的加持。随着其主力品种在全球份额的持续扩张、CDMO业务的快速增长以及创新药管线品种商业化进程的进一步提速，公司全年业绩增长的趋势将更加清晰，未来发展将更加值得期待。","news_type":1},"isVote":1,"tweetType":1,"viewCount":353,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}
